(Q33290854)
Statements
1 reference
A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia (English)
1 reference
Joseph P McEvoy
1 reference
David G Daniel
1 reference
William H Carson
1 reference
Robert D McQuade
1 reference
Ronald N Marcus
1 reference
13 July 2007
1 reference
1 reference
41
1 reference
11
1 reference
895-905
1 reference
Identifiers
1 reference
1 reference